Clinical trials of new coronary pneumonia drugs have been conducted in many African countries

Medicine Network December 23 - Recently, a number of African countries and international research institutions jointly launched a new coronary pneumonia drug clinical trials have been launched, aimed at finding effective treatment options for light and general patients of new coronary pneumonia, to reduce the pressure on national health systems.
the trial has been approved by the relevant national health department, participating volunteers can withdraw at any time, their personal information will be protected.
first in the Democratic Republic of the Congo and will continue in 13 African countries.
It was reported that the trial was led by doctors from participating countries to test the efficacy of specific drugs for light and general patients with neo-corona pneumonia, to study treatments suitable for health systems in African countries and other less developed countries and regions, to prevent the deterioration of the disease and to curb the spread of the virus.
data will be made public and shared globally and applied to the formulation of national public health policies.
, director of the African Center for Disease Control and Prevention, said Africa needs to conduct large-scale clinical trials of new crown pneumonia drugs to respond more effectively to outbreaks in Africa.
clinical trials could help improve WHO's ability to respond to the global outbreak of new coronary pneumonia, said Swaminathan, chief scientist at the World Health Organization.
, many African countries are facing a new wave of outbreak challenges.
The African Center for Disease Control and Prevention issued a statement calling on African countries to reassess the situation of epidemic prevention and control and carry out more active epidemic prevention work.
。